Aurora Cannabis (ACB) EBT (2017 - 2026)

Aurora Cannabis (ACB) has reported EBT for 10 consecutive years, with -$38.1 million the latest figure, recorded in Q1 2026.

• Quarterly EBT fell 1980.23% year-over-year to -$38.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$87.3 million (down 487.3% YoY) and the FY2026 annual result came in at -$86.9 million, down 486.18% from the prior year.
• EBT eased to -$38.1 million in Q1 2026 per ACB's latest filing, from -$1.1 million in the prior quarter.
• Over the last five years, EBT for ACB reached as high as $31.9 million in Q1 2024 and fell as low as -$4.8 billion in Q2 2023.
• A 5-year average of -$446.3 million and a median of -$13.3 million in 2023 frame the typical range for EBT.
• Annual changes were most pronounced in 2024 — EBT soared 257.82% — and 2025, when it plunged 12684.78%.
• Year by year, EBT stood at -$540.1 million in 2022, then soared by 97.67% to -$12.6 million in 2023, then surged by 257.82% to $19.9 million in 2024, then plunged by 105.7% to -$1.1 million in 2025, then plunged by 3262.28% to -$38.1 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$38.1 million, -$1.1 million, and -$34.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.